Researchers find less risky way to monitor breast cancer progression

by CU Anschutz Medical CampusSchematic for identifying subset of binding sites with TF footprints. (A) When TFs or nucleosomes are bound at TFBSs, they protect different lengths of DNA from nucle

Oncology February 20,2024

Researchers find less risky way to monitor breast cancer progression

by CU Anschutz Medical CampusSchematic for identifying subset of binding sites with TF footprints. (A) When TFs or nucleosomes are bound at TFBSs, they protect different lengths of DNA from nucle

Oncology February 20,2024

Drug that targets scar-like tissue in tumors shows promise for aggressive pancreatic cancer

by Garvan Institute of Medical ResearchThe new drug, PXS-5505, breaking down the fibrotic tissue around pancreatic cancer cells. Credit: Ella MaruFindings from the Garvan Institute of Medical Res

Oncology February 20,2024

Drug that targets scar-like tissue in tumors shows promise for aggressive pancreatic cancer

by Garvan Institute of Medical ResearchThe new drug, PXS-5505, breaking down the fibrotic tissue around pancreatic cancer cells. Credit: Ella MaruFindings from the Garvan Institute of Medical Res

Oncology February 20,2024

Researchers turn cancer cells into less harmful cell types

by University of BaselHigh-throughput drug screen reveals estrogen receptor α (ERα) induction in triple-negative breast cancer (TNBC) upon polo-like kinase 1 (PLK1) inhibition. A Schematic of the

Oncology February 20,2024

Researchers turn cancer cells into less harmful cell types

by University of BaselHigh-throughput drug screen reveals estrogen receptor α (ERα) induction in triple-negative breast cancer (TNBC) upon polo-like kinase 1 (PLK1) inhibition. A Schematic of the

Oncology February 20,2024

Study validates diagnostic assay for Asian cancers

by National University of SingaporeGraphical overview of workflow and coverage of cancer subtypes in the Asian Pan-Cancer Panel. A total of six workdays are required from sample QC to reliable ge

Oncology February 20,2024

Study validates diagnostic assay for Asian cancers

by National University of SingaporeGraphical overview of workflow and coverage of cancer subtypes in the Asian Pan-Cancer Panel. A total of six workdays are required from sample QC to reliable ge

Oncology February 20,2024

Toward a personalized approach to the study and treatment of bone cancers

by Lund UniversityPrimary acute myeloid leukemia cells preferentially home and engraft in MSOD-B hOss.a, Experimental scheme of AML patient sample transplantation. b, Representative histological

Oncology February 20,2024

Toward a personalized approach to the study and treatment of bone cancers

by Lund UniversityPrimary acute myeloid leukemia cells preferentially home and engraft in MSOD-B hOss.a, Experimental scheme of AML patient sample transplantation. b, Representative histological

Oncology February 20,2024

Liquid biopsy predicts early disease progression, potential survival in patients with advanced breast cancer

by Johns Hopkins UniversityCredit: Unsplash/CC0 Public DomainA novel, automated liquid biopsy test in development by researchers at the Johns Hopkins Kimmel Cancer Center can be used to predict e

Oncology February 20,2024

Liquid biopsy predicts early disease progression, potential survival in patients with advanced breast cancer

by Johns Hopkins UniversityCredit: Unsplash/CC0 Public DomainA novel, automated liquid biopsy test in development by researchers at the Johns Hopkins Kimmel Cancer Center can be used to predict e

Oncology February 20,2024

A comprehensive proteogenomic dataset to help cancer researchers unravel molecular mysteries

by National Institutes of HealthTumor types and data types of the CPTAC pan-cancer dataset. Overview of the available molecular data types for the CPTAC pan-cancer cohort (n= 1072, see Tabl

Oncology February 20,2024

A comprehensive proteogenomic dataset to help cancer researchers unravel molecular mysteries

by National Institutes of HealthTumor types and data types of the CPTAC pan-cancer dataset. Overview of the available molecular data types for the CPTAC pan-cancer cohort (n= 1072, see Tabl

Oncology February 20,2024

Researchers discover a new approach to boost the immune system

by Aarhus UniversityCancer cells. Credit: Dr. Cecil Fox, National Cancer InstituteImmunotherapy is a type of cancer treatment that uses the body's own immune system to fight tumor cells. Whil

Oncology February 20,2024

Researchers discover a new approach to boost the immune system

by Aarhus UniversityCancer cells. Credit: Dr. Cecil Fox, National Cancer InstituteImmunotherapy is a type of cancer treatment that uses the body's own immune system to fight tumor cells. Whil

Oncology February 20,2024

Researchers develop 'Goldilocks drug' to treat triple-negative breast cancer

by Mikayla Mace Kelley,University of ArizonacSNX1.3 competitively inhibits binding of EGFR to SNX1.ARibbon drawing of EGFR kinase domain (PDB ID 5CNO) and SNX1 Bar domain (PDB ID 4FZ

Oncology February 20,2024

Researchers develop 'Goldilocks drug' to treat triple-negative breast cancer

by Mikayla Mace Kelley,University of ArizonacSNX1.3 competitively inhibits binding of EGFR to SNX1.ARibbon drawing of EGFR kinase domain (PDB ID 5CNO) and SNX1 Bar domain (PDB ID 4FZ

Oncology February 20,2024

Researchers make major advance with cancer-killing antibody-drug conjugates

by Doug Bennett,University of FloridaCredit:Journal of Medicinal Chemistry(2023). DOI: 10.1021/acs.jmedchem.2c01771Building a new precision cancer treatment comes with no shortage of

Oncology February 20,2024

Researchers make major advance with cancer-killing antibody-drug conjugates

by Doug Bennett,University of FloridaCredit:Journal of Medicinal Chemistry(2023). DOI: 10.1021/acs.jmedchem.2c01771Building a new precision cancer treatment comes with no shortage of

Oncology February 20,2024